Rationale, design and baseline patient characteristics of the optimal type 2 diabetes management including benchmarking and standard treatment study in Greece

Table 5 Laboratory evaluation of the study population in Greece (mean ± SD)

Variable	Values
Glucose (mg/dL)	138 ± 47
HbA1c (%)	7.2 ± 1.3
LDL-C (mg/dL)	112 ± 35
HDL-C (mg/dL)	50 ± 13
TC (mg/dL)	192 ± 42
TG (mg/dL)	154 ± 85
Albuminuria (mg/g Cr)	66.6 ± 249.2

HbA1c: Glycosylated hemoglobin; LDL-C: Low density lipoprotein cholesterol; HDL-C: High density lipoprotein cholesterol; TC: Total cholesterol; TG: Triglycerides; Cr: Creatinine.